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Distinguishing true coagulase-negative staphylococci bacteremia from 2 
contamination remains a challenge. We conducted a retrospective analysis of 183 3 
patients with methicillin-resistant coagulase-negative staphylococci (MR-CoNS)–4 
positive and methicillin-resistant Staphylococcus aureus–positive cultures obtained 5 
from sterile sites such as blood, synovial fluid, ascitic fluid, and cerebrospinal fluid. Of 6 
the 209 MR-CoNS isolates, 83 (39.7%) were considered infection associated and 126 7 
(60.3%) were considered contamination. MR-CoNS isolates cultured from synovial 8 
fluid were more likely to be infection associated (P = 0.009). The median interval from 9 
insertion of a central venous catheter to onset of infection tended to be longer in 10 
MR-CoNS infection cases than in methicillin-resistant S. aureus infection cases (41 11 
days versus 14 days, P = 0.055). In conclusion, our results suggest that the proportion of 12 
cases of true MR-CoNS infection may be higher than previously reported.  13 
 14 
  15 
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1. Introduction 1 
Some coagulase-negative staphylococci (CoNS) species are among the main species 2 
of the normal resident skin flora (Roth and James, 1988). Therefore, CoNS isolates from 3 
clinical specimens are often considered contaminants, especially when the specimens 4 
are obtained from sterile sites. However, some reports have indicated the importance of 5 
CoNS, which account for more than 30% of blood culture isolates (Gaynes, et al., 1996; 6 
Richards, et al., 1999a, 1999b; Wisplinghoff, et al., 2004). Most CoNS infections occur 7 
in patients with indwelling medical devices (Otto, 2009). Additionally, the central 8 
venous catheterization procedure rate is increasing (Glickman, et al., 2010), suggesting 9 
that the number of CoNS infections may also be increasing.  10 
 It remains difficult and challenging to distinguish true CoNS bacteremia from 11 
contamination (Hall and Lyman, 2006). Although several investigators have proposed 12 
methods to determine the clinical significance of CoNS isolates from blood cultures, 13 
multiple positive blood culture results are not sufficient to determine true bacteremia 14 
(Beekmann, et al., 2005; Mirrett, et al., 2001; Seo, et al., 2000; Seybold, et al., 2009). 15 
Accordingly, the rate of true CoNS bacteremia has been reported to range from 10% to 16 
30% in published reports (Beekmann, et al., 2005; Finkelstein, et al., 2002; Herwaldt, et 17 
al., 1996; Mirrett, et al., 2001; Souvenir, et al., 1998; Weinstein, et al., 1997). 18 
5 
 
Many studies of contamination rates only involve blood cultures. Additionally, 1 
most of these studies were conducted more than 10 years ago. Therefore, we conducted 2 
a retrospective analysis of 183 patients with methicillin-resistant CoNS (MR-CoNS)–3 
positive and methicillin-resistant Staphylococcus aureus (MRSA)-positive cultures that 4 
were obtained from sterile sites such as synovial fluid, ascitic fluid, and cerebrospinal 5 
fluid as well as blood. In this study, we focused on methicillin-resistant isolates, which 6 
are important drug-resistant pathogens. MRSA was also included to compare clinical 7 
aspects with MR-CoNS. 8 
 9 
2. Materials and methods 10 
 11 
2.1 Study setting  12 
This study was conducted at Toyama University Hospital (Japan), a 612-bed tertiary 13 
care and teaching hospital with an annual average of 180,000 patient discharges. 14 
Between January 2009 and December 2012, all cultures obtained from sterile sites in 15 
adult patients (older than 18 years of age) that yielded MRSA and MR-CoNS were 16 
identified through a review of the electronic microbiology records. The sterile sites from 17 
which specimens were collected included blood, pleural fluid, ascitic fluid, 18 
cerebrospinal fluid, synovial fluid, subcutaneous wounds, and closed abscesses. If more 19 
6 
 
than 3 types of bacteria or fungi were isolated from an ascitic fluid specimen, the result 1 
was excluded from the analysis because of the high possibility of contamination with 2 
gut flora. Isolate identification and antimicrobial susceptibility testing were assessed by 3 
using the MicroScan WalkAway 96 SI (Siemens Healthcare, Erlangen, Germany) 4 
according to the manufacturer’s instructions. The panels used were MicroScan Dried 5 
Pos ID 2 (PID2), MicroScan Dried Gram Pos Combo 6.1J, and MicroScan Dried Gram 6 
Pos MIC 6.3J (Siemens Healthcare, Erlangen, Germany). 7 
 8 
2.2 Definition of infection  9 
Most infections, including bloodstream infections, were defined according to the 10 
standard definitions of the US Centers for Disease Control and Prevention (Horan, et al., 11 
2008). Catheter-related bloodstream infection (CRBSI) was diagnosed when the same 12 
organism grew from at least one percutaneous blood culture and from a catheter tip 13 
culture (Mermel, et al., 2009). Decisions regarding contamination in all specimen types 14 
were made after the following factors were considered: the patient’s clinical history, 15 
physical findings, body temperature at the time of culture, leukocyte count, C-reactive 16 
protein level, number of positive blood cultures, culture results of specimens from other 17 
sites, imaging results, clinical course, and response to therapy (Weinstein, et al., 1997). 18 
7 
 
Briefly, the absence of specific physical and laboratory findings or an improvement in 1 
the response to treatment with ineffective antibiotics such as β-lactams indicated 2 
contamination. Episodes that could only be effectively treated with anti-MRSA 3 
antibiotics were considered infections. If both MRSA and MR-CoNS were cultured 4 
from the same specimen, the specimen was considered MRSA infected but not 5 
MR-CoNS infected because MRSA is a more invasive pathogen than MR-CoNS. 6 
Culture positive results reported for a given specimen within 1 month were counted as a 7 
single episode. The criteria for hospital-acquired infection were as follows: the 8 
causative agent was cultured more than 48 h after admission; the patient had a history of 9 
hospitalization, surgery, dialysis, or residence in a long-term health care facility within 6 10 
months before the culture was obtained; and the patient had an indwelling intravenous 11 
line, catheter, or any other percutaneous medical device when the culture was obtained 12 
(Huang, et al., 2006). 13 
 14 
2.3 Data collection  15 
The following data for patients with bloodstream infections (including CRBSIs) were 16 
extracted from the clinical records: age; sex; risk factors such as underlying conditions 17 
(e.g., diabetes mellitus, neoplasm, and immunosuppressive therapy), the presence of 18 
8 
 
intravascular devices, and previous surgeries; clinical signs; results of laboratory 1 
studies; antibiotic therapies; and death within 30 days. The duration of hospital stay, 2 
interval from admission to onset, and interval from insertion of a central venous catheter 3 
to onset were also examined. For patients transferred from other facilities, the duration 4 
of hospital stay included the duration of hospitalization at both institutions.  5 
 6 
2.4 Statistical analysis  7 
Differences in the group proportions were assessed by using the chi-square or Fisher 8 
exact test. Continuous variables were compared by using the Mann-Whitney test. 9 
Statistical analyses were performed by using Prism version 5.0 (GraphPad, Inc., San 10 
Diego, CA, USA). Differences were considered significant at a P value <0.05.  11 
 12 
3. Results 13 
During the study period, 284 cultures obtained from sterile sites in 183 patients were 14 
MRSA or MR-CoNS positive; these yielded 335 microorganisms, including 126 MRSA 15 
and 209 MR-CoNS isolates. Ninety-four patients had 106 infection episodes: 58 were 16 




3.1 Rate of contamination  1 
Of the 126 MRSA isolates, 115 (91.3%) were considered infection associated and 11 2 
(8.7%) were considered contamination. Of the 11 latter isolates, 9 were cultured from 3 
blood and 2 were cultured from a closed abscess; the most common reason for 4 
considering contamination was that the clinical symptoms and laboratory data improved 5 
after treatment with an antimicrobial agent known to be ineffective against MRSA 6 
infection, such as a β-lactam. Of the 209 MR-CoNS isolates, 83 (39.7%) were 7 
considered infection associated and 126 (60.3%) were considered contamination. The 8 
proportions of infection-associated or contaminant isolates for each specimen are shown 9 
in Table 1. These proportions remained the same even if the type of specimen was 10 
limited to blood (39.6%). If only the initially cultured isolates from the blood of each 11 
patient were evaluated, the proportion of infection decreased to 33.3%. MR-CoNS 12 
isolates cultured from synovial fluid were significantly more likely to be infection 13 
associated than isolates cultured from other specimens (5/83 vs. 0/126, P = 0.009).  14 
Given the lack of criteria regarding clinical signs or symptoms in the definition of 15 
CRBSI, we also confirmed clinical characteristics in patients with CRBSI to avoid 16 
overestimating the incidence of infection. Of the 44 CRBSI-associated MR-CoNS 17 
isolates in this study, 38 were obtained from patients with fever (≥38°C), 4 were 18 
10 
 
obtained from patients with hypotension (<90 mm Hg), and 3 were obtained from 1 
patients with neutropenia (<500 cells/μL). Some patients had more than one of these 3 2 
factors.  3 
We also examined the possibility that the study population comprised patients with a 4 
potentially higher risk of infection than the general hospital population. Of the 83 5 
infection-associated MR-CoNS isolates, only 3 were obtained from patients in the 6 
intensive care unit; 77 isolates were from patients in the general ward, and 3 isolates 7 
were obtained from patients of the outpatient clinic. None of the study participants were 8 
bone marrow transplant recipients. Twelve MR-CoNS isolates were obtained from 9 
patients with hematologic malignancies.  10 
 11 
3.2 MR-CoNS species  12 
The proportions of each MR-CoNS species obtained from sterile sites are shown in 13 
Table 2 and are classified as infection or contamination. Staphylococcus epidermidis 14 
was the dominant species, responsible for 75.9% of all MR-CoNS infections. Of the 154 15 
MR-CoNS blood culture isolates, 101 (65.6%) were of S. epidermidis; of these, 45 16 
(44.6%) were infection-associated isolates. Among the cases of infection, S. epidermis 17 
was followed in prevalence by Staphylococcus hominis (9.6%), Staphylococcus capitis 18 
11 
 
(8.4%), Staphylococcus warneri (2.4%), and Staphylococcus schleiferi (2.4%). However, 1 
among the cases of contamination, S. epidermidis accounted for only 60.3% of cases, 2 
followed by S. hominis (14.0%), Staphylococcus haemolyticus (8.1%), S. capitis (6.6%), 3 
and Staphylococcus simulans (5.0%). S. epidermidis was more prevalent among the 4 
cases of infection (P = 0.025); however; S. haemolyticus and S. simulans were more 5 
prevalent among the cases of contamination (P = 0.007 and 0.041, respectively). 6 
Staphylococcus saprophyticus, which usually causes urinary tract infections, was not 7 
detected in this study.  8 
 9 
3.3 Community-acquired or hospital-acquired organisms  10 
Of the 335 MRSA- and MR-CoNS–positive cultures, 297 isolates were obtained more 11 
than 48 h after admission and 38 were cultured within 48 h of admission; the latter 12 
included 12 MRSA isolates (32%) and 26 MR-CoNS isolates (68%). Of the 38 isolates 13 
cultured within 48 h, 36 were considered hospital-acquired organisms according to the 14 
clinical definition; therefore, 333 isolates were hospital acquired. Only 2 S. simulans 15 
isolates were considered community-acquired isolates.  16 
 17 
3.4 Difference between MRSA and MR-CoNS infection  18 
12 
 
We next compared the clinical features between the 58 MRSA and 48 MR-CoNS cases 1 
of infection. The types of infection are shown in Table 3. The proportion of CRBSIs was 2 
higher among MR-CoNS infections than among MRSA infections (62.5% versus 24.1%, 3 
P < 0.001). In contrast, among bone and joint infections, the proportion of MRSA 4 
infections was higher than that of MR-CoNS infections (P = 0.021). No single 5 
Staphylococcus species was isolated among prosthetic joint infections. 6 
A comparison between MRSA and MR-CoNS infections with respect to the clinical 7 
characteristics of bloodstream infections (including CRBSIs) is summarized in Table 4. 8 
The MRSA-infected patients were older than the MR-CoNS–infected patients (68.8 9 
years versus 59.7 years, P = 0.016). The median interval from insertion of a central 10 
venous catheter to the onset of infection tended to be longer in the cases of MR-CoNS 11 
infection than in the cases of MRSA infection (41 days versus 14 days, P = 0.055). The 12 
mortality rate with MRSA infection was 25%, which was higher than that with 13 
MR-CoNS infection (2.9%, P = 0.016). Vital signs on the day of the positive blood 14 
culture were similar. However, leukocyte counts and C-reactive protein levels tended to 15 
be higher in the cases of MRSA infection than in the cases of MR-CoNS infection (P = 16 
0.082 and P = 0.023, respectively). Regarding underlying conditions, the rates of use of 17 
a central venous catheter exceeded 80% for both infection groups, especially among 18 
13 
 
cases of MR-CoNS infection, for which 33 of 34 episodes involved central venous 1 
catheters. The most commonly used initial drugs for the treatment of both MRSA and 2 
MR-CoNS infections were vancomycin and teicoplanin. In some cases, removal of a 3 
central venous catheter resulted in clinical improvement without antibiotics. In other 4 
cases not treated with anti-MRSA drugs, the patients died before the culture results 5 
became available. 6 
 7 
4. Discussion 8 
In this study, we analyzed and compared various aspects of cases involving MRSA 9 
and MR-CoNS cultures. Initially, we evaluated each positive culture obtained from 10 
sterile sites to distinguish true infection from contamination because some CoNS 11 
species are among the main species of normal resident skin flora (Roth and James, 12 
1988). In this study, the percentage of MRSA contamination among blood cultures was 13 
similar to that in a previous report (6.4%) (Weinstein, et al., 1997).  14 
On the other hand, 39.7% of the MR-CoNS–positive cultures were considered true 15 
infections, which is a higher proportion than previously reported (5%–30%) (Beekmann, 16 
et al., 2005; Finkelstein, et al., 2002; Hall and Lyman, 2006; Herwaldt, et al., 1996; 17 
Natoli, et al., 2009; Souvenir, et al., 1998; Weinstein, et al., 1997). There were some 18 
differences in the settings of our study and those previously reported. First, various 19 
14 
 
specimen types were included in our study, whereas previously published studies only 1 
evaluated blood cultures. Even so, our results limited to blood cultures showed higher 2 
infection rates compared with the results of previous studies. Second, the scope of our 3 
study was limited to methicillin-resistant species. We chose to study 4 
methicillin-resistant isolates only because this would enable precise decisions regarding 5 
the presence or absence of a true infection, according to the requirement for anti-MRSA 6 
drugs. Third, we adopted a definitive diagnosis of CRBSI that only required the growth 7 
of the same organism from at least one percutaneous blood culture and a catheter tip 8 
culture. However, we confirmed that most determinations of true infection-associated 9 
CRBSI in this study met the requirements defined in previous studies, with regard to, 10 
for example, clinical signs. Fourth, multiple samples may have been taken from the 11 
same patient over a short interval. However, the proportion of cases of infection among 12 
the initially cultured isolates from blood only in each patient remained higher than the 13 
proportions reported in previous studies. Fifth, there was no evidence to indicate the 14 
possibility that this study population might comprise patients at a potentially higher risk 15 
of infection than the general hospital population, such as bone marrow transplant 16 
recipients, patients with hematologic malignancies, and patients in intensive care units 17 
(Herwaldt, et al., 1996). These results indicated the possibility that the incidence of 18 
15 
 
CoNS infection may have increased in recent years compared with the rate in the 1990s. 1 
This is not surprising because patient populations and treatment modes have changed 2 
over time and, in particular, the rate of central venous catheterization has increased 3 
(Glickman, et al., 2010).  4 
One of the objectives of this study was to examine differences in the clinical 5 
significance of MR-CoNS infection in blood and other sterile specimens. Most 6 
specimens from sterile sites are normally collected via percutaneous puncture, and 7 
therefore, microbes from the normal skin flora could likely contaminate those 8 
specimens. We therefore expected that the infection-associated rates for each type of 9 
specimen would be nearly identical. Indeed, most rates of contamination for other types 10 
of specimens were similar to that in blood. However, an MR-CoNS–positive culture 11 
from synovial fluid was more likely to be associated with infection. The pretest 12 
probability for synovial fluid collection may be higher than that for other sterile 13 
specimens (e.g., blood); however, the number of isolates in this study was small, and a 14 
larger number of cases would have to be studied to confirm this hypothesis. 15 
S. epidermidis was the dominant MR-CoNS species in this study and was more likely 16 
to be infection associated than contamination, as previously reported (Chu, et al., 2008; 17 
Finkelstein, et al., 2002; Herwaldt, et al., 1996; Kloos and Bannerman, 1994). 18 
16 
 
Conversely, S. haemolyticus and S. simulans were less likely to be infection associated 1 
and were always considered contamination in this study. Herwaldt et al. indicated that 2 
non-S. epidermidis species blood culture isolates were less likely to be infection 3 
associated. Another potential concern in this study was the false identification of 4 
Staphylococcus species. MicroScan WalkAway, which was used for identification, has 5 
been reported to have poor reliability for some uncommon CoNS strains (Olendzki, et 6 
al., 2014). Unlike other species, the identification of S. epidermidis, S. haemolyticus, 7 
and S. hominis was reported to be sufficiently reliable in the same study. The authors 8 
also reported that the automated system showed 100% specificity and 90% sensitivity 9 
for the detection of oxacillin resistance. Our results indicate the need for careful 10 
evaluation, especially for uncommon CoNS strains.  11 
In our study, rates of hospital-acquired infection were higher than those in previous 12 
studies (Beekmann, et al., 2005; Finkelstein, et al., 2002; Herwaldt, et al., 1996; 13 
Weinstein, et al., 1997). The main reason for this difference is that we used the timing 14 
criterion of “not only 48 h after admission” as well as other detailed criteria such as a 15 
history of hospitalization. Second, we investigated only methicillin-resistant species. 16 
Indeed, Cherifi et al. found that S. epidermidis CRBSI, which was considered hospital 17 
acquired, was significantly resistant to more antibiotics when compared with S. 18 
17 
 
epidermidis isolates obtained from healthy volunteers (Cherifi, et al., 2013).  1 
The clinical features and outcomes differ between S. aureus and CoNS infections. S. 2 
aureus is an aggressive pathogen that causes various invasive and fatal infections. In 3 
contrast, S. epidermidis is usually associated with infections of implanted medical 4 
devices such as central venous catheters (Pfaller and Herwaldt, 1988). We confirmed 5 
that MR-CoNS caused CRBSI more frequently than MRSA. This finding is compatible 6 
with the fact that S. epidermidis is responsible for 50% to 70% of catheter-related 7 
infections (von Eiff, et al., 2002). Interestingly, the proportion of bone and joint 8 
infections was higher among MRSA infections than among MR-CoNS infections. This 9 
might have been due to differences in S. aureus pathogenicity, including the production 10 
of enterotoxins, exotoxins, leukocidins, and leukotoxins that is not observed in S. 11 
epidermidis infection (Gill, et al., 2005). 12 
In conclusion, our results suggest that the proportion of true cases of MR-CoNS 13 
infection is higher than previously reported. The MR-CoNS contamination rates in 14 
blood and other sterile site specimens, excluding synovial fluid, were similar. Because 15 
patient populations and treatment modes change over time, we urge the continued 16 
monitoring of both S. aureus and CoNS infections.  17 
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Table 1. Sterile specimens with isolated methicillin-resistant coagulase-
negative staphylococci
No. (%) of isolates
Specimens (n) Infection-associated isolates Contaminants P value
Blood (154) 61(39.6) 93(60.4) 0.960
Subcutaneous wound (13) 8(61.5) 5(38.5) 0.097
Synovial fluid (5) 5(100.0) 0(0.0) 0.009
Ascitic fluid (18) 4(22.2) 14(77.8) 0.113
Closed abscess (13) 3(23.1) 10(76.9) 0.379
Cerebrospinal fluid (4) 2(50.0) 2(50.0) 0.650
Pleural fluid (2) 0(0.0) 2(100.0) 0.519
All (209) 83(39.7) 126(60.3)
Table 1.  Tashiro et al.
Table 2.  Tashiro et al.
Table 2. Methicillin-resistant coagulase-negative staphylococci isolated from sterile sitesa
No. (%) of isolates per indicated category




(n = 126) P value
Staphylococcus epidermidis 139(66.5) 63(75.9) 76(60.3) 0.019
Staphylococcus hominis 25(12.0) 8(9.6) 17(14.0) 0.401
Staphylococcus capitis 15(7.2) 7(8.4) 8(6.6) 0.568
Staphylococcus haemolyticus 10(4.8) 0(0.0) 10(8.1) 0.007
Staphylococcus lugdunensis 6(2.9) 1(1.2) 5(4.1) 0.406
Staphylococcus simulans 6(2.9) 0(0.0) 6(5.0) 0.083
Staphylococcus warneri 4(1.9) 2(2.4) 2(1.7) 0.650
Staphylococcus schleiferi 2(1.0) 2(2.4) 0(0.0) 0.157
Staphylococcus sciuri 1(0.5) 0(0.0) 1(0.8) 1.000
Staphylococcus intermedius 1(0.5) 0(0.0) 1(0.8) 1.000
aSpecimens were collected from sterile sites, including blood, pleural fluid, ascitic fluid, cerebrospinal 
fluid, synovial fluid, subcutaneous wounds, and closed abscesseStaphylococcus
Table 3.  Tashiro et al.
Table 3. Comparison of types of infection between MRSA and MR-CoNS 
infections
No. (%) of episodes per indicated category
Type of infection MRSA (n = 58) MR-CoNS (n = 48) P value
Surgical site 16(27.6) 10(20.8) 0.421
Catheter-related bloodstream 14(24.1) 30(62.5) <0.001
Bloodstream 10(17.2) 4(8.3) 0.177
Bone and joint 9(15.5) 1(2.1) 0.021
Skin and soft tissue 4(6.9) 1(2.1) 0.374
Lower respiratory tract 3(5.2) 0(0.0) 0.250
Gastrointestinal system 1(1.7) 1(2.1) 1.000
Cardiovascular system 1(1.7) 1(2.1) 1.000
MRSA, methicillin-resistant Staphylococcus aureus; MR-CoNS, methicillin-resistant 
coagulase-negative staphylococci.
Table 4.  Tashiro et al.
Table 4. Comparison of clinical characteristics of bloodstream infectionsa
Causative microorganism
Variable MRSA (n = 24) MR-CoNS (n = 34) P value
Age (years) 68.8± 9.5 59.7±15.5 0.016
Male sex 15(62.5) 21(61.8) 0.954
Length of hospital stay (days) 97(20-407) 102(29-525) 0.468
Length from admission to onset (days) 41(0-294) 45(0-437) 0.554
Length from CVC insertion to onset (days) 14(1-537) 41(6-970) 0.055
Duration of antibiotic therapy (days) 15(0-45) 8(0-70) 0.099
Death within 30 days 6(25.0) 1(2.9) 0.016
Vital signs and laboratory data
Body temperature (°C) 38.6±0.6 38.9±0.8 0.050
Systolic blood pressure (mm Hg) 111.6±19.1 115.7±22.6 0.770
Leukocyte (/μL) 12,033.3±8797.7 7850.6±5290.2 0.082
Hemoglobin (g/dL) 9.2±2.3 9.6±2.2 0.517
Platelet (×103/μL) 16.8±12.2 21.4±15.3 0.280
C-reactive protein (mg/dL) 10.2±7.4 6.3±5.8 0.023
Albumin (g/dL) 2.8±0.6 2.8±0.6 0.521
Creatinine (mg/dL) 1.0±0.7 1.0±0.7 0.818
Sodium (mEq/L) 136.0±6.0 136.4±4.8 0.652
Underlying condition
Recent surgery (previous 30 days) 7(29.2) 9(26.5) 0.820
CVC 20(83.3) 33(97.1) 0.149
Diabetes mellitus 5(20.8) 6(17.6) 1.000
Neoplasm 13(54.2) 19(55.9) 0.897
Immunosuppressive therapy 12(50.0) 11(32.4) 0.176




Values are mean ± SD, n (%), and median (minimum to maximum).aBloodstream infections in this table include catheter-related bloodstream infection
MRSA, methicillin-resistant Staphylococcus aureus; MR-CoNS, methicillin-resistant coagulase-
negative staphylococci; CVC, central venous catheter; SD, standard deviation.
